Celebrex (celecoxib) is the first drug to be approved for a hereditary form of colorectal cancer
February 2000
Celebrex (celecoxib) is the first drug to be approved for a hereditary form of colorectal cancer.
It'll be used to help reduce the number of intestinal polyps in patients with familial adenomatous polyposis (FAP).
Blocking the COX-2 enzyme seems to reduce blood supply to the polyp and therefore inhibit growth.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote